Pleiotropic effects of statins on acute kidney injury: involvement of Krüppel-like factor 4

Tadashi Yoshida, Matsuhiko Hayashi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Statins, the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are potent cholesterol-lowering drugs used for primary and secondary prevention of coronary artery disease. They also possess multiple beneficial effects independent of their cholesterol-lowering properties, which are called as their “pleiotropic” effects. The results of recent studies have revealed that statins exert their pleiotropic effects in the kidneys, in that they are protective against acute kidney injury (AKI). Moreover, Krüppel-like factor 4, a zinc-finger transcription factor, in endothelial cells has been identified as a novel mediator of statins. This article summarizes the pleiotropic effects of statins on AKI, and reviews the recent progress in our understanding of the regulatory mechanisms involved in statin-mediated protection against AKI.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalClinical and Experimental Nephrology
DOIs
Publication statusAccepted/In press - 2016 Jun 13

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Acute Kidney Injury
Zinc Fingers
Primary Prevention
Secondary Prevention
Coronary Artery Disease
Transcription Factors
Endothelial Cells
Cholesterol
Kidney
Pharmaceutical Preparations

Keywords

  • 3-Hydroxy-3-methylglutaryl-coenzyme A
  • Cholesterol
  • Krüppel-like factors
  • Pleiotropic effect

ASJC Scopus subject areas

  • Nephrology
  • Physiology
  • Physiology (medical)

Cite this

Pleiotropic effects of statins on acute kidney injury : involvement of Krüppel-like factor 4. / Yoshida, Tadashi; Hayashi, Matsuhiko.

In: Clinical and Experimental Nephrology, 13.06.2016, p. 1-7.

Research output: Contribution to journalArticle

@article{4de08f72563a4da39d4515256e9c6189,
title = "Pleiotropic effects of statins on acute kidney injury: involvement of Kr{\"u}ppel-like factor 4",
abstract = "Statins, the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are potent cholesterol-lowering drugs used for primary and secondary prevention of coronary artery disease. They also possess multiple beneficial effects independent of their cholesterol-lowering properties, which are called as their “pleiotropic” effects. The results of recent studies have revealed that statins exert their pleiotropic effects in the kidneys, in that they are protective against acute kidney injury (AKI). Moreover, Kr{\"u}ppel-like factor 4, a zinc-finger transcription factor, in endothelial cells has been identified as a novel mediator of statins. This article summarizes the pleiotropic effects of statins on AKI, and reviews the recent progress in our understanding of the regulatory mechanisms involved in statin-mediated protection against AKI.",
keywords = "3-Hydroxy-3-methylglutaryl-coenzyme A, Cholesterol, Kr{\"u}ppel-like factors, Pleiotropic effect",
author = "Tadashi Yoshida and Matsuhiko Hayashi",
year = "2016",
month = "6",
day = "13",
doi = "10.1007/s10157-016-1286-4",
language = "English",
pages = "1--7",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Pleiotropic effects of statins on acute kidney injury

T2 - involvement of Krüppel-like factor 4

AU - Yoshida, Tadashi

AU - Hayashi, Matsuhiko

PY - 2016/6/13

Y1 - 2016/6/13

N2 - Statins, the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are potent cholesterol-lowering drugs used for primary and secondary prevention of coronary artery disease. They also possess multiple beneficial effects independent of their cholesterol-lowering properties, which are called as their “pleiotropic” effects. The results of recent studies have revealed that statins exert their pleiotropic effects in the kidneys, in that they are protective against acute kidney injury (AKI). Moreover, Krüppel-like factor 4, a zinc-finger transcription factor, in endothelial cells has been identified as a novel mediator of statins. This article summarizes the pleiotropic effects of statins on AKI, and reviews the recent progress in our understanding of the regulatory mechanisms involved in statin-mediated protection against AKI.

AB - Statins, the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are potent cholesterol-lowering drugs used for primary and secondary prevention of coronary artery disease. They also possess multiple beneficial effects independent of their cholesterol-lowering properties, which are called as their “pleiotropic” effects. The results of recent studies have revealed that statins exert their pleiotropic effects in the kidneys, in that they are protective against acute kidney injury (AKI). Moreover, Krüppel-like factor 4, a zinc-finger transcription factor, in endothelial cells has been identified as a novel mediator of statins. This article summarizes the pleiotropic effects of statins on AKI, and reviews the recent progress in our understanding of the regulatory mechanisms involved in statin-mediated protection against AKI.

KW - 3-Hydroxy-3-methylglutaryl-coenzyme A

KW - Cholesterol

KW - Krüppel-like factors

KW - Pleiotropic effect

UR - http://www.scopus.com/inward/record.url?scp=84974846105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974846105&partnerID=8YFLogxK

U2 - 10.1007/s10157-016-1286-4

DO - 10.1007/s10157-016-1286-4

M3 - Article

C2 - 27294581

AN - SCOPUS:84974846105

SP - 1

EP - 7

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

ER -